{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T23:08:46Z","timestamp":1785452926550,"version":"3.56.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T00:00:00Z","timestamp":1733443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T00:00:00Z","timestamp":1733443200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-024-03627-4","type":"journal-article","created":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T18:34:49Z","timestamp":1733510089000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Defining high-risk patients: beyond the 8the AJCC melanoma staging system"],"prefix":"10.1007","volume":"317","author":[{"given":"Elisabetta","family":"Broseghini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Veronesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo","family":"Gardini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5053-4172","authenticated-orcid":false,"given":"Federico","family":"Venturi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biagio","family":"Scotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Vespi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola Valeria","family":"Marchese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Melotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Comito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Corti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Ferracin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3186-2861","authenticated-orcid":false,"given":"Emi","family":"Dika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,6]]},"reference":[{"issue":"8","key":"3627_CR1","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1245\/s10434-018-6513-7","volume":"25","author":"JE Gershenwald","year":"2018","unstructured":"Gershenwald JE, Scolyer RA (2018) Melanoma Staging: American Joint Committee on Cancer (AJCC) 8th Edition and Beyond. Ann Surg Oncol 25(8):2105\u20132110","journal-title":"Ann Surg Oncol"},{"key":"3627_CR2","doi-asserted-by":"crossref","unstructured":"Papageorgiou C et al (2021) Melanoma: staging and Follow-Up. Dermatol Pract Concept, 11(Suppl 1):e2021162S.","DOI":"10.5826\/dpc.11S1a162S"},{"issue":"4","key":"3627_CR3","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1200\/JCO.2017.75.7724","volume":"36","author":"SL Wong","year":"2018","unstructured":"Wong SL et al (2018) Sentinel Lymph Node Biopsy and Management of Regional Lymph nodes in Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Clinical Practice Guideline Update. J Clin Oncol 36(4):399\u2013413","journal-title":"J Clin Oncol"},{"key":"3627_CR4","doi-asserted-by":"crossref","unstructured":"Branisteanu DE et al (2022) Sentinel Lymph Node Biopsy in Cutaneous Melanoma, a clinical point of View. Med (Kaunas), 58(11)","DOI":"10.3390\/medicina58111589"},{"key":"3627_CR5","doi-asserted-by":"crossref","unstructured":"Reschke R, Gussek P, Ziemer M (2021) Identifying high-risk tumors within AJCC Stage IB-III melanomas using a seven-marker immunohistochemical signature. Cancers (Basel), 13(12)","DOI":"10.3390\/cancers13122902"},{"issue":"9","key":"3627_CR6","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1093\/jnci\/djaa008","volume":"112","author":"S Bajaj","year":"2020","unstructured":"Bajaj S et al (2020) Melanoma Prognosis: Accuracy of the American Joint Committee on Cancer Staging Manual Eighth Edition. J Natl Cancer Inst 112(9):921\u2013928","journal-title":"J Natl Cancer Inst"},{"key":"3627_CR7","doi-asserted-by":"publisher","unstructured":"Zocchi L, Lontano A, Merli M, Dika E, Nagore E, Quaglino P, Puig S, Ribero S (2021) Familial Melanoma and Susceptibility Genes: A Review of the Most Common Clinical and Dermoscopic Phenotypic Aspect, Associated Malignancies and Practical Tips for Management. J Clin Med. 10(16):3760. https:\/\/doi.org\/10.3390\/jcm10163760. PMID: 34442055","DOI":"10.3390\/jcm10163760"},{"issue":"9","key":"3627_CR8","doi-asserted-by":"publisher","first-page":"e0257949","DOI":"10.1371\/journal.pone.0257949","volume":"16","author":"CQ Yang","year":"2021","unstructured":"Yang CQ et al (2021) Integrating additional factors into the TNM staging for cutaneous melanoma by machine learning. PLoS ONE 16(9):e0257949","journal-title":"PLoS ONE"},{"issue":"8","key":"3627_CR9","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1002\/jso.26214","volume":"122","author":"J Bleicher","year":"2020","unstructured":"Bleicher J et al (2020) Recurrence patterns in patients with stage II melanoma: the evolving role of routine imaging for surveillance. J Surg Oncol 122(8):1770\u20131777","journal-title":"J Surg Oncol"},{"issue":"3","key":"3627_CR10","doi-asserted-by":"publisher","first-page":"205","DOI":"10.2217\/fon-2022-0969","volume":"19","author":"A Winge-Main","year":"2023","unstructured":"Winge-Main A et al (2023) Long-term outcomes of stage IIB-IV melanoma patients: nationwide data from Norway. Future Oncol 19(3):205\u2013215","journal-title":"Future Oncol"},{"issue":"6","key":"3627_CR11","doi-asserted-by":"publisher","first-page":"472","DOI":"10.3322\/caac.21409","volume":"67","author":"JE Gershenwald","year":"2017","unstructured":"Gershenwald JE et al (2017) Melanoma staging: evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin 67(6):472\u2013492","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"3627_CR12","doi-asserted-by":"publisher","first-page":"e14165","DOI":"10.1111\/dth.14165","volume":"33","author":"F Scarf\u00ec","year":"2020","unstructured":"Scarf\u00ec F et al (2020) The role of topical imiquimod in melanoma cutaneous metastases: a critical review of the literature. Dermatol Ther 33(6):e14165. https:\/\/doi.org\/10.1111\/dth.14165Epub 2020 Sep 7. PMID: 32772481","journal-title":"Dermatol Ther"},{"key":"3627_CR13","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ejca.2019.06.011","volume":"119","author":"T Kanaki","year":"2019","unstructured":"Kanaki T et al (2019) Impact of American Joint Committee on Cancer 8th edition classification on staging and survival of patients with melanoma. Eur J Cancer 119:18\u201329","journal-title":"Eur J Cancer"},{"issue":"9","key":"3627_CR14","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1080\/14737140.2023.2247565","volume":"23","author":"P Rutkowski","year":"2023","unstructured":"Rutkowski P, Czarnecka AM (2023) Pembrolizumab for the adjuvant treatment of IIB or IIC melanoma. Expert Rev Anticancer Ther 23(9):897\u2013902","journal-title":"Expert Rev Anticancer Ther"},{"issue":"11","key":"3627_CR15","doi-asserted-by":"publisher","first-page":"2835","DOI":"10.1038\/s41591-023-02583-2","volume":"29","author":"JM Kirkwood","year":"2023","unstructured":"Kirkwood JM et al (2023) Adjuvant nivolumab in resected stage IIB\/C melanoma: primary results from the randomized, phase 3 CheckMate 76K trial. Nat Med 29(11):2835\u20132843","journal-title":"Nat Med"},{"issue":"3","key":"3627_CR16","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1200\/JCO.22.00533","volume":"41","author":"JS Weber","year":"2023","unstructured":"Weber JS et al (2023) Adjuvant therapy of Nivolumab Combined with Ipilimumab Versus Nivolumab alone in patients with Resected Stage IIIB-D or Stage IV Melanoma (CheckMate 915). J Clin Oncol 41(3):517\u2013527","journal-title":"J Clin Oncol"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-03627-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-024-03627-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-03627-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T19:04:28Z","timestamp":1733511868000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-024-03627-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,6]]},"references-count":16,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3627"],"URL":"https:\/\/doi.org\/10.1007\/s00403-024-03627-4","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,6]]},"assertion":[{"value":"17 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"78"}}